Skip to main content

and
  1. Article

    Open Access

    Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer

    Programmed cell death-ligand 1 (PD-L1) on tumor cells can be degraded to soluble form (sPD-L1) and enter circulation, however, the clinical significances of sPD-L1 in peripheral blood remains to be elucidated ...

    Koji Teramoto, Tomoyuki Igarashi, Yoko Kataoka in Cancer Immunology, Immunotherapy (2023)

  2. No Access

    Article

    Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer

    Programmed cell death-ligand 1 (PD-L1) expression on tumor cells is induced by interferon-gamma, suggesting the induction of an anti-tumor immune response. In turn, binding of PD-L1 to programmed cell death 1 ...

    Koji Teramoto, Tomoyuki Igarashi, Yoko Kataoka in Cancer Immunology, Immunotherapy (2021)

  3. No Access

    Chapter

    Roles of Signaling Pathways in Cancer Cells and Immune Cells in Generation of Immunosuppressive Tumor-Associated Microenvironments

    Cancer cells trigger multiple immunosuppressive cascades and generate immunosuppressive tumor-associated microenvironments including tumor and sentinel lymph nodes. Constitutive activation of various signaling...

    Yutaka Kawakami, Tomonori Yaguchi, Hidetoshi Sumimoto in The Tumor Immunoenvironment (2013)

  4. Article

    Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells

    Myeloid cell leukemia-1 (Mcl-1) is an anti-apoptotic protein that regulates apoptosis sensitivity in a variety of cell types. Here we evaluate the roles of Mcl-1 in chemotherapy-associated apoptosis in gastric...

    Hideko Akagi, Hajime Higuchi, Hidetoshi Sumimoto, Toru Igarashi in Gastric Cancer (2013)

  5. No Access

    Article

    Immunological detection of altered signaling molecules involved in melanoma development

    To understand immune responses to human cancer and develop more effective immunotherapy, human tumor antigens has been isolated using various immunological methods with tumor reactive T cells or antibodies obt...

    Yutaka Kawakami, Hidetoshi Sumimoto, Tomonobu Fujita in Cancer and Metastasis Reviews (2005)